A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma

Type of Cancer
Skin and Soft Tissue
Locations
Hackensack
Sponsor
SWOG
Protocol Number
SWOG S1404
Cancer Diagnosis
To Learn More Call
201-510-0910